Post-streptococcal glomerulonephritis primary prevention: Difference between revisions
No edit summary |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Effective measures for the primary prevention of [[post-streptococcal glomerulonephritis]] include improving hand hygiene, better housing, prevent overcrowding, treatment of infected patient within 24 hours with [[antibiotics]] and prevent close contact. A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis. | Effective measures for the primary prevention of [[post-streptococcal glomerulonephritis]] include improving hand hygiene, better housing, prevent overcrowding, treatment of an infected patient within 24 hours with [[antibiotics]] and prevent close contact. A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis. | ||
==Primary Prevention== | ==Primary Prevention== | ||
*Effective measures for the primary prevention of post-streptococcal glomerulonephritis include: | *Effective measures for the primary prevention of post-streptococcal glomerulonephritis include: | ||
Revision as of 16:42, 12 June 2018
|
Post-streptococcal glomerulonephritis Microchapters |
|
Differentiating Post-streptococcal glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post-streptococcal glomerulonephritis primary prevention On the Web |
|
American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis primary prevention |
|
FDA on Post-streptococcal glomerulonephritis primary prevention |
|
CDC on Post-streptococcal glomerulonephritis primary prevention |
|
Post-streptococcal glomerulonephritis primary prevention in the news |
|
Blogs on Post-streptococcal glomerulonephritis primary prevention |
|
Directions to Hospitals Treating Post-streptococcal glomerulonephritis |
|
Risk calculators and risk factors for Post-streptococcal glomerulonephritis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Effective measures for the primary prevention of post-streptococcal glomerulonephritis include improving hand hygiene, better housing, prevent overcrowding, treatment of an infected patient within 24 hours with antibiotics and prevent close contact. A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.
Primary Prevention
- Effective measures for the primary prevention of post-streptococcal glomerulonephritis include:
- Spread of group A streptococcal infection should be reduced by following methods:[1]
- Improving hand hygiene
- Better housing
- Prevent overcrowding
- Treatment of infected patient within 24 hours with antibiotics
- Prevent close contact
- Spread of group A streptococcal infection should be reduced by following methods:[1]
- A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.[2]
References
- ↑ "Group A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC".
- ↑ Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (July 2005). "Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes". Clin. Diagn. Lab. Immunol. 12 (7): 833–6. doi:10.1128/CDLI.12.7.833-836.2005. PMC 1182208. PMID 16002631.